Here are three updates on GI companies from the past week:
Pentax Medical obtained a CE Mark for its DEC Duodenoscope.
VolitionRx is planning a European launch of its CRC screening product in 2018.
Immuron is making progress on its three clinical trials for IMM-124E, a nonalcoholic steatohepatitis and nonalcoholic fatty liver disease treatment.